Kristina Leslie Sells 1,200 Shares of Hinge Health (NYSE:HNGE) Stock

Posted by Stanley Muller on Aug 23rd, 2026

Hinge Health Inc. (NYSE:HNGE – Get Free Report) Director Kristina Leslie sold 1,200 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $88.23, for a total value of $105,876.00. Following the sale, the director directly owned 30,387 shares in the company, valued at $2,681,045.01. This trade represents a 3.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Hinge Health Stock Up 3.3%

Shares of NYSE HNGE opened at $88.44 on Friday. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $93.13. The company has a market cap of $7.14 billion, a price-to-earnings ratio of 69.09 and a beta of 1.30. The business has a fifty day simple moving average of $81.40 and a 200-day simple moving average of $58.29.

Hinge Health (NYSE:HNGE – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.31. The firm had revenue of $212.82 million for the quarter. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%.The company’s revenue for the quarter was up 53.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.59 EPS. As a group, sell-side analysts expect that Hinge Health Inc. will post 1.25 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC lifted its position in Hinge Health by 3.3% in the 1st quarter. Janney Montgomery Scott LLC now owns 9,400 shares of the company’s stock worth $362,000 after buying an additional 300 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after acquiring an additional 336 shares in the last quarter. Nykredit A S purchased a new position in shares of Hinge Health during the 2nd quarter valued at $29,000. Lazard Asset Management LLC increased its stake in shares of Hinge Health by 0.6% in the first quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock worth $2,456,000 after acquiring an additional 386 shares during the last quarter. Finally, First Horizon Corp increased its stake in shares of Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after acquiring an additional 531 shares during the last quarter.

Analysts Set New Price Targets

Several brokerages recently commented on HNGE. Evercore restated an “outperform” rating and issued a $105.00 price target on shares of Hinge Health in a research report on Wednesday, August 5th. Citigroup reissued an “outperform” rating on shares of Hinge Health in a research note on Monday, July 27th. Royal Bank Of Canada increased their target price on Hinge Health from $75.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Citizens Jmp raised their target price on Hinge Health from $96.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 5th. Finally, KeyCorp lifted their price target on Hinge Health from $90.00 to $125.00 and gave the company an “overweight” rating in a report on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $100.57.

Read Our Latest Stock Report on HNGE

Hinge Health Company Profile

(Get Free Report)

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.